Prescription Drug Prices

July 17, 1992 • Volume 2, Issue 26
Should the government regulate prescription drug prices?
By Julie Rovner


The U.S. pharmaceutical industry is among the most profitable sectors of the nation's otherwise lagging economy. It's also one of the few bright spots on the international trade scene. But an increasing number of consumer advocates, as well as some lawmakers, say that many prescription drugs are becoming so costly they are beyond the reach of those they could help. Condemning pharmaceutical companies for spending as much marketing their products as they do inventing new ones, the critics say it is time for the federal government to step in and regulate drug prices. Drug manufacturers contend that their products not only help lower medical costs by preventing costly hospitalization and surgery but also reduce the toll in human suffering.

ISSUE TRACKER for Related Reports
May 20, 2016  Prescription Drug Costs
Oct. 11, 2013  Regulating Pharmaceuticals
Oct. 09, 2009  Medication Abuse
Mar. 11, 2005  Drug Safety
Jun. 06, 2003  Drug Company Ethics
Sep. 03, 1999  Drugmakers Under Siege
Jul. 17, 1992  Prescription Drug Prices
Nov. 25, 1959  High Price of Drugs
Consumer Protection and Product Liability